Fujifilm’s new endosurgical image enhancement technology gets FDA nod

0
15

Lexington, Mass.- July 8, 2021 – FUJIFILM Medical Systems U.S.A., Inc.- a leading provider of endoscopic imaging and endosurgical solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Fujifilm’s new image enhancement technology – the Oxygen Saturation Endoscopic Imaging System – which was developed to improve visualization during gastrointestinal, colorectal, and advanced endoscopy and surgical procedures. The new image enhancement technology enables real-time visualization of hemoglobin oxygen saturation (StO2) levels in tissue using laparoscopic and/or endoscopic imaging. Being able to detect StO2 levels helps surgeons identify potentially ischemic tissue, better positioning them to prevent tissue necrosis.

“The prognosis is poor for tissue necrosis resulting from GI procedural complications and the reduction in mortality relies on early detection and intervention,” says Taisuke…

Read more…